Lactobacillus Predominance

Lactobacillus predominance describes a microbial community in which Lactobacillus species are the dominant bacteria, most often referring to the vaginal microbiome. These organisms metabolize glycogen-derived substrates to produce lactic acid, helping maintain an acidic environment that can limit growth or colonization by some potentially harmful microbes; certain strains also produce other antimicrobial compounds. In medicine, assessing Lactobacillus predominance can support interpretation of vaginal microbiome profiles and their relationship to reproductive and genitourinary health. Changes in dominance may accompany dysbiosis, infection, hormonal shifts, or treatment, making this pattern relevant to diagnosis, risk assessment, and microbiome-focused research.

Lactobacillus Predominance - Related Videos

Research

JoVE EoE - Immunotherapy

An Assay To Evaluate the Anticancer Effects of Lactobacillus Cell-Free Supernatant

0 Views •

2025

This video demonstrates an in vitro assay to study the anticancer effects of Lactobacillus cell-free supernatant (LCFS). Upon exposing colorectal cancer spheroids to varying doses of LCFS, the interaction with the bacterial metabolites in LCFS induces apoptosis in the cancer cells, disrupting the spheroid structure and leading to cell death in a dose-dependent manner.

Education

JoVE Core - Pharmacology

Drugs for Treatment of Diarrhea-Predominant IBS

0 Views •

2024

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions. Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

Drugs for Treatment of Constipation-Predominant IBS

0 Views •

2024

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...

Research

JoVE Journal - Biology
Free Sample

Cell Block Preparation from Cytology Specimen with Predominance of Individually Scattered Cells

0 Views •

Cited by 67 •

2009

Shidham's method for preparation of cell blocks with AV-marker from cytology specimens containing individually scattered cells and small cell groups.

Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease

0 Views •

Cited by 1 •

2022

This article describes two protocols: 1) adjunctive diode laser therapy for treating periodontitis and 2) probiotic Lactobacillus therapy for treating peri-implant disease, with emphasis on the laser usage mode (inside or outside pocket), laser application regimen (single or multiple sessions), and a probiotic protocol of professional and home administration.

View All Results

FAQs

Related Topics